The Worldwide Endoscopy Visualization Systems Industry is Expected to Reach $35 Billion by 2028


You May Also Like

Genmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid Tumors

  Company Announcement Seattle Genetics exercises option to co-develop & co-commercialize tisotumab vedotin Costs and ...

Updated Data from Ongoing MAGE-A10 and MAGE-A4 Studies Presented at the 2018 ESMO Congress

PHILADELPHIA and OXFORD, United Kingdom, Oct. 20, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc ...